Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CancerCodeTM Informed, Molecularly Targeted Therapies in Non-small Cell Lung Cancer

NCT02132884 is registered in ClinicalTrials.gov with Fox Chase Cancer Center as lead sponsor.

NCT NCT02132884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02132884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CancerCodeTM Informed, Molecularly Targeted Therapies in Non-small Cell Lung Cancer
Lead sponsor
Fox Chase Cancer Center
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2015
Completion date
August 31, 2016
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pericardial effusion, malignant pleural effusion, recurrent non-small cell lung cancer, stage iiib non-small cell lung cancer, stage iv non-small cell lung cancer